These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18428958)

  • 1. Disulfide conjugation of peptides to oligonucleotides and their analogs.
    Turner JJ; Williams D; Owen D; Gait MJ
    Curr Protoc Nucleic Acid Chem; 2006 Apr; Chapter 4():Unit 4.28. PubMed ID: 18428958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A convenient method for the synthesis of oligonucleotide-cationic peptide conjugates.
    Ferenc G; Kupihár Z; Kele Z; Kovács L
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):1059-61. PubMed ID: 16248092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward high yield synthesis of peptide-oligonucleotide chimera through a disulfide bridge: a simplified method for oligonucleotide activation.
    Maurel F; Debart F; Cavelier F; Thierry AR; Lebleu B; Vasseur JJ; Vivès E
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5084-7. PubMed ID: 16168651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfide bridge as a linker in nucleic acids' bioconjugation. Part II: A summary of practical applications.
    Stasińska AR; Putaj P; Chmielewski MK
    Bioorg Chem; 2020 Jan; 95():103518. PubMed ID: 31911308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragment-based solid-phase assembly of oligonucleotide conjugates with peptide and polyethylene glycol ligands.
    Dirin M; Urban E; Noe CR; Winkler J
    Eur J Med Chem; 2016 Oct; 121():132-142. PubMed ID: 27236069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfide bridge as a linker in nucleic acids' bioconjugation. Part I: An overview of synthetic strategies.
    Stasińska AR; Putaj P; Chmielewski MK
    Bioorg Chem; 2019 Nov; 92():103223. PubMed ID: 31494329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of double-stranded oligonucleotides using backbone-linked disulfide bridges.
    Gao H; Yang M; Cook AF
    Nucleic Acids Res; 1995 Jan; 23(2):285-92. PubMed ID: 7862534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
    Turner JJ; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Application of Peptide-siRNA Nanoparticles from Disulfide-Constrained Cyclic Amphipathic Peptides for the Functional Delivery of Therapeutic Oligonucleotides to the Lung.
    Welch JJ; Dean DA; Nilsson BL
    Methods Mol Biol; 2021; 2208():49-67. PubMed ID: 32856255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Synthesis of 2'-O-Methoxyethyl Oligonucleotide-Cationic Peptide Conjugates.
    Halloy F; Hill AC; Hall J
    ChemMedChem; 2021 Nov; 16(22):3391-3395. PubMed ID: 34358416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting protected maleimides to modify oligonucleotides, peptides and peptide nucleic acids.
    Paris C; Brun O; Pedroso E; Grandas A
    Molecules; 2015 Apr; 20(4):6389-408. PubMed ID: 25867825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, dynamic combinatorial chemistry, and PCR amplification of 3'-5' and 3'-6' disulfide-linked oligonucleotides.
    Hansen DJ; Manuguerra I; Kjelstrup MB; Gothelf KV
    Angew Chem Int Ed Engl; 2014 Dec; 53(52):14415-8. PubMed ID: 25413927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a steroid cyclic disulfide anchor in constructing gold nanoparticle-oligonucleotide conjugates.
    Letsinger RL; Elghanian R; Viswanadham G; Mirkin CA
    Bioconjug Chem; 2000; 11(2):289-91. PubMed ID: 10725107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncovalent peptide-mediated delivery of chemically modified steric block oligonucleotides promotes splice correction: quantitative analysis of uptake and biological effect.
    Laufer SD; Recke AL; Veldhoen S; Trampe A; Restle T
    Oligonucleotides; 2009 Mar; 19(1):63-80. PubMed ID: 19196099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-LNA oligonucleotide conjugates.
    Astakhova IK; Hansen LH; Vester B; Wengel J
    Org Biomol Chem; 2013 Jul; 11(25):4240-9. PubMed ID: 23681061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of oligonucleotide-peptide conjugates for biomedical and technological applications.
    Aviñó A; Grijalvo S; Pérez-Rentero S; Garibotti A; Terrazas M; Eritja R
    Methods Mol Biol; 2011; 751():223-38. PubMed ID: 21674334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native chemical ligation in the synthesis of internally modified oligonucleotide-peptide conjugates.
    Diezmann F; Eberhard H; Seitz O
    Biopolymers; 2010; 94(4):397-404. PubMed ID: 20593471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-Specific Conjugation of Peptides and Proteins via Rebridging of Disulfide Bonds Using the Thiol-Yne Coupling Reaction.
    Griebenow N; Dilmaç AM; Greven S; Bräse S
    Bioconjug Chem; 2016 Apr; 27(4):911-7. PubMed ID: 27031217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic oligonucleotide-peptide conjugates with aggregating properties enter efficiently into cells while maintaining hybridization properties and enzymatic recognition.
    Fraley AW; Pons B; Dalkara D; Nullans G; Behr JP; Zuber G
    J Am Chem Soc; 2006 Aug; 128(33):10763-71. PubMed ID: 16910671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of oligonucleotide-peptide and oligonucleotide-protein conjugates.
    Corey DR
    Methods Mol Biol; 2004; 283():197-206. PubMed ID: 15197311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.